News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
683,275 Results
Type
Article (38967)
Company Profile (276)
Press Release (644032)
Section
Business (203825)
Career Advice (1985)
Deals (35358)
Drug Delivery (84)
Drug Development (80768)
Employer Resources (168)
FDA (16085)
Job Trends (14796)
News (344469)
Policy (32432)
Tag
Academia (2530)
Alliances (49035)
Alzheimer's disease (1215)
Approvals (16004)
Artificial intelligence (116)
Bankruptcy (352)
Best Places to Work (11465)
Biotechnology (196)
Breast cancer (107)
Cancer (898)
Cardiovascular disease (81)
Career advice (1656)
Cell therapy (198)
Clinical research (63918)
Collaboration (326)
Compensation (168)
COVID-19 (2522)
Cystic fibrosis (78)
Data (862)
Diabetes (133)
Diagnostics (6096)
Earnings (84141)
Employer resources (146)
Events (108844)
Executive appointments (247)
FDA (16529)
Funding (288)
Gene therapy (148)
GLP-1 (557)
Government (4318)
Healthcare (18656)
Infectious disease (2597)
Inflammatory bowel disease (102)
Interviews (308)
IPO (16268)
Job creations (3622)
Job search strategy (1415)
Layoffs (407)
Legal (7850)
Lung cancer (154)
Manufacturing (151)
Medical device (13147)
Medtech (13152)
Mergers & acquisitions (19109)
Metabolic disorders (361)
Neuroscience (1455)
NextGen Class of 2024 (6499)
Non-profit (4463)
Northern California (1205)
Obesity (214)
Opinion (176)
Patents (94)
People (56127)
Phase I (19821)
Phase II (28144)
Phase III (21014)
Pipeline (210)
Postmarket research (2553)
Preclinical (8429)
Radiopharmaceuticals (234)
Rare diseases (178)
Real estate (5888)
Regulatory (21441)
Research institute (2307)
Resumes & cover letters (349)
Southern California (1082)
Startups (3560)
United States (11626)
Vaccines (537)
Weight loss (159)
Date
Today (203)
Last 7 days (829)
Last 30 days (2866)
Last 365 days (35778)
2024 (30363)
2023 (40076)
2022 (51174)
2021 (55712)
2020 (54087)
2019 (46542)
2018 (35027)
2017 (32113)
2016 (31480)
2015 (37552)
2014 (31319)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27329)
Location
Africa (713)
Arizona (187)
Asia (37011)
Australia (6037)
California (2725)
Canada (1175)
China (209)
Colorado (117)
Connecticut (121)
Europe (79234)
Florida (392)
Georgia (99)
Illinois (306)
Indiana (177)
Kansas (95)
Maryland (515)
Massachusetts (2217)
Michigan (143)
Minnesota (250)
New Jersey (825)
New York (836)
North Carolina (662)
Northern California (1205)
Ohio (126)
Pennsylvania (745)
South America (1091)
Southern California (1082)
Texas (381)
Utah (79)
Washington State (321)
683,275 Results for "anthem inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Protagonist Earns $10 Million Payment for Achievement of Clinical Milestone in Phase 2b ANTHEM-UC Study of JNJ-2113 in Adults with Moderately to Severely Active Ulcerative Colitis
Protagonist Therapeutics, Inc. today announced it has earned a $10 million milestone payment following the dosing of the third patient in ANTHEM-UC, a Phase 2b trial to evaluate the safety and effectiveness of JNJ-2113 compared with placebo in participants with moderately to severely active ulcerative colitis.
December 13, 2023
·
5 min read
BioMidwest
Relievant Medsystems Announces Positive Coverage Policy for the Intracept Procedure from Anthem Blue Cross and Blue Shield
Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic low back pain, announced that Anthem Blue Cross and Blue Shield has established favorable coverage for the Intracept® Procedure.
October 3, 2023
·
3 min read
Biotech Beach
MicroVascular Tissues’ mVASC(R) Microvascular Tissue Allograft Covered by Anthem and Amerigroup
MicroVascular Tissues, Inc., a regenerative tissue company, announces effective 12/28/2022, Anthem Blue Cross Blue Shield and Amerigroup added coverage of mVASC® Microvascular Tissue Allograft for the treatment of diabetic foot ulcers.
April 25, 2023
·
1 min read
BioCapital
Senseonics Announces a Positive Coverage Decision for Eversense® E3 CGM from Anthem
Senseonics Holdings, Inc. today announced that Anthem is providing coverage for implantable CGM, which includes the Eversense® CGM System.
August 3, 2022
·
5 min read
INSIGHTEC ANNOUNCES POSITIVE COVERAGE DECISION BY ANTHEM FOR MR-GUIDED FOCUSED ULTRASOUND TO TREAT ESSENTIAL TREMOR
Insightec®, a global healthcare company dedicated to using acoustic energy to transform patient care, announced today that Anthem is the third national payor to cover MR-guided Focused Ultrasound for treating medication-refractory Essential Tremor.
December 22, 2022
·
3 min read
BioMidwest
Anthem, Inc. Completes Acquisition of myNEXUS Home Health Benefits Manager
Anthem, Inc. announced that it has completed its acquisition of myNEXUS, Inc., a comprehensive home-based nursing management company for payors.
April 29, 2021
·
7 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
BioMidwest
Inspire Medical Systems, Inc. Announces Positive Coverage Policy Issued by Anthem for Inspire Therapy
Inspire Medical Systems, Inc., a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced that Anthem, Inc. will provide coverage for the Company’s Inspire therapy, effective May 20, 2021.
May 20, 2021
·
3 min read
Press Releases
Verrica Pharmaceuticals Announces Litigation Settlement with Dormer Laboratories, Inc.
Verrica Pharmaceuticals Inc. today announced the settlement of litigation with Dormer Laboratories, Inc. (“Dormer Labs”).
July 1, 2024
·
5 min read
Deals
Anthem Offering Financial Incentives to Encourage All Associates to Receive COVID-19 Vaccination
Anthem, Inc. announced that it will provide a $50 incentive to all associates who are fully vaccinated against COVID-19.
April 7, 2021
·
2 min read
1 of 68,328
Next
